Pyrimidine-based dual-target inhibitors targeting epidermal growth factor receptor for overcoming drug resistance in cancer therapy(2006-present)

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 9055f8402d92ce44-LAX IP: 116.62.10.13 UTC time: 2025-01-21T08:35:14+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4